Latest Co-Diagnostics News & Updates

See the latest news and media coverage for Co-Dx. We track all announcements, press releases, and industry mentions in real time, all in one place.

Co-Diagnostics (Co-Dx)

Real-time PCR diagnostic test developer

co-dx.com

Headquarters: Salt Lake City, United States
Founded year: 2013
Company type: Public company
Number of employees: 80–200

Last updated Today

Latest news about Co-Diagnostics (Co-Dx)

In short: Co-Dx expanded its diagnostic footprint through a Saudi Arabian joint venture, international distribution deals, and Ebola test research.

Company announcements

July 1 Co-Dx

Co-Dx completed clinical studies for FDA submission of a respiratory test

Over 1,400 patients enrolled across 9 sites; 27 analytical studies performed. Submission targeted for Q3 2026.

May 26 Co-Dx

Co-Dx advances Ebola PCR assay development with joint venture CoSara

The strategy aims to address international deployment needs if the Ebola outbreak expands globally.

May 20 Co-Dx

Co-Dx announces $3.0 million private placement

The offering includes common stock and warrants, priced at $1.821 per unit.

May 19 Co-Dx

Co-Dx develops Ebola assay strategy after global outbreak alert

The strategy for Bundibugyo virus is complete, allowing rapid test availability if needed, following WHO and CDC alerts.

Media coverage

July 1 Yahoo Finance

EXCLUSIVE: Co-Diagnostics Reaches Regulatory Milestone for PCR Respiratory Test Platform

Co-Diagnostics Inc. (NASDAQ:CODX) on Wednesday said it completed clinical and analytical performance studies for the Co-Dx PCR Flu A/B & RSV upper respiratory multiplex test...

June 2 Yahoo Finance

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today...

May 27 Yahoo Finance

Co-Diagnostics (CODX) Q4 2025 Earnings Transcript

On the line today from Co-Diagnostics, we have Dwight Egan, Chief Executive Officer; and Brian Brown, Chief Financial Officer. Earlier today,...

May 22 The Globe and Mail

Co-Diagnostics Announces $3 Million Private Placement Financing

Detailed price information for Co-Diagnostics Inc (CODX-Q) from The Globe and Mail including charting and trades.

Never miss news about Co-Dx

Track Co-Dx and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Co-Dx competitors & trending companies

Browse news for competitors to Co-Dx and other trending companies.